TY - JOUR
T1 - Twenty-four new cases of WT1 germline mutations and review of the literature
T2 - Genotype/phenotype correlations for Wilms tumor development
AU - Royer-Pokora, Brigitte
AU - Beier, Manfred
AU - Henzler, Markus
AU - Alam, Rita
AU - Schumacher, Valérie
AU - Weirich, Angela
AU - Huff, Vicki
PY - 2004/6
Y1 - 2004/6
N2 - We report here 24 new Wilms tumor (WT) patients with germline WT1 alterations and a synopsis of our own previously described and literature cases in whom age of tumor-onset, gender, and laterality were known. This combined database contains 282 patients, 117 patients with and 165 without WT1 germline alterations. Using this information we have determined the median age of tumor-onset for patients with (12.5 months) and without WT1 gene alterations (36 months). The earliest onset was in patients with truncation (12 mo, 66 patients), followed by missense mutations (18 mo, 30 patients) and deletions (22 mo, 21 patients). Patients with the two most frequent nonsense mutations R362X and R390X and the Denys-Drash syndrome (DDS) hot spot mutation R394W/Q/L had a very early onset (9, 12, and 18 mo, respectively). The highest number of bilateral tumors was observed in the group of truncation mutations, with a higher percentage of bilateral tumors when truncations occurred in the 5′ half of the WT1 gene. In addition to genital tract anomalies (GU), early onset nephrotic syndrome with diffuse mesangial sclerosis and stromal-predominant histology, tumor bilaterality, and early age of onset can now be added to the list of risk factors for carrying a germline WT1 mutation.
AB - We report here 24 new Wilms tumor (WT) patients with germline WT1 alterations and a synopsis of our own previously described and literature cases in whom age of tumor-onset, gender, and laterality were known. This combined database contains 282 patients, 117 patients with and 165 without WT1 germline alterations. Using this information we have determined the median age of tumor-onset for patients with (12.5 months) and without WT1 gene alterations (36 months). The earliest onset was in patients with truncation (12 mo, 66 patients), followed by missense mutations (18 mo, 30 patients) and deletions (22 mo, 21 patients). Patients with the two most frequent nonsense mutations R362X and R390X and the Denys-Drash syndrome (DDS) hot spot mutation R394W/Q/L had a very early onset (9, 12, and 18 mo, respectively). The highest number of bilateral tumors was observed in the group of truncation mutations, with a higher percentage of bilateral tumors when truncations occurred in the 5′ half of the WT1 gene. In addition to genital tract anomalies (GU), early onset nephrotic syndrome with diffuse mesangial sclerosis and stromal-predominant histology, tumor bilaterality, and early age of onset can now be added to the list of risk factors for carrying a germline WT1 mutation.
KW - Age of onset
KW - Bilateral WT
KW - Germline WT1 alterations
KW - WT1 genoptype/phenotype
KW - Wilms tumor (WT)
UR - http://www.scopus.com/inward/record.url?scp=2542462400&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2542462400&partnerID=8YFLogxK
M3 - Article
C2 - 15150775
AN - SCOPUS:2542462400
SN - 1552-4825
VL - 127
SP - 249
EP - 257
JO - American Journal of Medical Genetics
JF - American Journal of Medical Genetics
IS - 3
ER -